secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2026-04-22T23:59:59+00:00
Accession:  0001193125-26-168907
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma files 1-for-30 reverse stock split to maintain Nasdaq listing
---------------------------------------------------------------------------

- 1-for-30 reverse stock split effective 5:00 PM ET on April 23, 2026; no fractional shares, cash in lieu.
- Common stock begins trading post-split on April 24 under symbol CUE; new CUSIP 22978P205.
- Reverse split aims to meet Nasdaq minimum bid price requirement, as disclosed in proxy statement.
- No change in authorized shares ($0.001 par); options and warrants proportionately adjusted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000119312526168907/0001193125-26-168907-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000119312526168907/cue-20260422.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-168907

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer